Announcement on the Plan to Repurchase Part of the Public Shares

Announcement on the Plan to Repurchase Part of the Public Shares

Innovative Medical Management Co., Ltd. and all members of the board of directors guarantee that the information disclosed is true, accurate, and complete, without false records, misleading statements, or major omissions.

Important Content Reminder:

1. In light of the recent continuous decline in the stock price of Innovative Medical Management Co., Ltd. (hereinafter referred to as "the Company"), the stock price has dropped by a cumulative 20% over twenty consecutive trading days (from April 30, 2026, to June 1, 2026), and the closing price is below 50% of the highest closing price in the past year. Based on firm confidence in the Company's future development and value assessment, to enhance investor confidence, support long-term development, and improve operational capability, the Company has decided to repurchase its shares using its own funds through centralized bidding, as necessary to maintain the Company's value and shareholder rights.

2. The total amount for this share repurchase will not be less than RMB 50 million (inclusive) and not exceed RMB 100 million (inclusive). The funds for this repurchase will come from the Company's own funds. Based on the total share capital of 441,284,352 shares as of May 31, 2026, and under the condition that the repurchase price does not exceed RMB 20 per share, it is estimated that approximately 5,000,000 shares can be repurchased, accounting for about 1.13% of the total issued share capital; under the lower limit of the repurchase amount, approximately 2,500,000 shares can be repurchased, accounting for about 0.57% of the total issued share capital. The specific number of shares repurchased will be based on the actual number at the end of the repurchase period. The implementation period for the repurchase of shares is within three months from the date of the board's approval of this repurchase plan.

3. As of the date of this announcement, the Company's controlling shareholders, actual controllers, and their concerted actions, directors, and senior management have no explicit plans for share reduction during the repurchase period and the following three to six months. If there are plans for share reduction in the future, the Company will fulfill its information disclosure obligations in a timely manner according to relevant regulations.

4. Risk Warning:

   • (1) There is a risk that the funds required for the share repurchase may not be raised, leading to the inability to implement the repurchase plan.
   • (2) There is a risk that the stock price may continue to exceed the upper limit of the repurchase price disclosed in the plan during the repurchase period, leading to the inability to implement the plan or only partial implementation.
   • (3) There is a risk that significant events affecting the stock trading price may occur, or the board may decide to terminate the repurchase plan, leading to the inability to implement the plan.
   • (4) The Company will fulfill its information disclosure obligations in a timely manner based on the progress of the repurchase matter; investors should pay attention to risks.

According to the Company Law, Securities Law, and the relevant regulations of the Shenzhen Stock Exchange, the seventh board meeting of the Company held on June 1, 2026, approved the proposal on the repurchase of part of the public shares. The specific content is announced as follows:

Main Content of the Repurchase Plan

(1) Purpose of the Share Repurchase

In light of the recent continuous decline in the Company's stock price, which has dropped by a cumulative 20% over twenty consecutive trading days (from April 30, 2026, to June 1, 2026), and the closing price being below 50% of the highest closing price in the past year, the Company has firm confidence in its future development and value assessment. The repurchase aims to enhance investor confidence, support long-term development, and improve operational capability, considering business prospects, operational conditions, financial status, future profitability, and recent market performance.